HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Same Legislative Focus For Consumer Health As Its Hill Champions Change

Executive Summary

OTC drug and dietary supplement industries still emphasize lobbying for allowing direct purchases of their [products with pre-tax health savings accounts; streamlining FDA's process for adding OTC monograph ingredients and indications; and making multivitamins eligible for purchase with food stamps. They also remain vigilant about keeping Congress' hands off DSHEA, which reaches its 25th anniversary in October.

You may also be interested in...



Making Some Supplements Eligible For US Pre-Tax Savings Accounts Proposed Again In Congress

Dietary supplements would be covered in pre-tax health savings accounts under Senate legislation. Industry groups say the health and economic impact of COVID-19 makes including supplements in the accounts more important. 

COVID-19 Magnifies US Need To Make Supplements Eligible For Pre-Tax Savings – NPA

NPA asks Congress to include supplements in legislation defining "medical expenses” covered by pre-tax health savings accounts. The trade group says industry would prefer supplements were included with OTC drugs in provision in recently passed COVID-19 relief legislation that changed pre-tax account rules.

HBW Legislative News: Another Federal CR, Michigan On DXM List, Senators Say Supplements Are 'Medical Expenses'

Federal agencies at FY 2019 funding for another month; Michigan imposes age restriction on OTC DXM sales; and senators urge IRS to make supplements 'medical expenses'.

Related Content

Topics

UsernamePublicRestriction

Register

RS148472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel